Piramal Pharma Appoints Brian Guy as President and COO of Piramal Critical Care
Piramal Pharma Ltd 路 Change in Management 路 30 Sept 2026, 11:25 pm
Piramal Pharma Appoints Brian Guy as President and COO of Piramal Critical Care Piramal Pharma Limited announced the appointment of Brian Guy as President and COO of Piramal Critical Care, effective 19th Oct'26, following the retirement of Jeffrey Hampton on 27th Nov'26. Guy brings over 25 years of pharmaceutical industry experience in commercial operations and business leadership, having previously served as President and Chief Commercial Officer at Breckenridge Pharmaceutical, Inc. with full U.S. P&L responsibility since 2018. In his new role, Guy will focus on driving expansion within the company's Complex Hospital Generics portfolio.
Original exchange filing (PDF)
More announcements from Piramal Pharma Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund 路 31 Oct 2026
- Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI LODR Regulations, 2015 路 30 Oct 2026
- Please find enclosed details of Earning call Transcript held on 28th October 2026. 路 30 Oct 2026
- Please find enclosed intimation of audio recordings of the conference call held today 28th October, 2026. 路 28 Oct 2026
- Please find enclosed Investor presentation for quarter ended 30 September, 2026 路 28 Oct 2026
- Please find enclosed Press release for quarter ended 30 September, 2026 路 28 Oct 2026
- Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 28 Oct 2026
- Please find enclosed unaudited financial results for Q2 FY 27 路 28 Oct 2026
